Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Clinical colorectal cancer - 23(2024), 1 vom: 05. März, Seite 1-3 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Giuliani, Jacopo [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.03.2024 Date Revised 05.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.clcc.2023.10.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36423962X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36423962X | ||
| 003 | DE-627 | ||
| 005 | 20240405233206.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clcc.2023.10.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1366.xml |
| 035 | |a (DE-627)NLM36423962X | ||
| 035 | |a (NLM)37932152 | ||
| 035 | |a (PII)S1533-0028(23)00093-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Giuliani, Jacopo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.03.2024 | ||
| 500 | |a Date Revised 05.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bevacizumab | |
| 650 | 4 | |a Cost of drugs | |
| 650 | 4 | |a Metastatic colorectal cancer | |
| 650 | 4 | |a Third-line | |
| 650 | 4 | |a Trifluridine/tipiracil | |
| 650 | 7 | |a tipiracil |2 NLM | |
| 650 | 7 | |a NGO10K751P |2 NLM | |
| 650 | 7 | |a Bevacizumab |2 NLM | |
| 650 | 7 | |a 2S9ZZM9Q9V |2 NLM | |
| 650 | 7 | |a Trifluridine |2 NLM | |
| 650 | 7 | |a RMW9V5RW38 |2 NLM | |
| 650 | 7 | |a Drug Combinations |2 NLM | |
| 650 | 7 | |a Uracil |2 NLM | |
| 650 | 7 | |a 56HH86ZVCT |2 NLM | |
| 650 | 7 | |a Pyrrolidines |2 NLM | |
| 650 | 7 | |a Thymine |2 NLM | |
| 650 | 7 | |a QR26YLT7LT |2 NLM | |
| 700 | 1 | |a Mantoan, Beatrice |e verfasserin |4 aut | |
| 700 | 1 | |a Mangiola, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Muraro, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Napoli, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Tommasi, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Fiorica, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Mandarà, Marta |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical colorectal cancer |d 2000 |g 23(2024), 1 vom: 05. März, Seite 1-3 |w (DE-627)NLM122314204 |x 1938-0674 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2024 |g number:1 |g day:05 |g month:03 |g pages:1-3 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clcc.2023.10.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2024 |e 1 |b 05 |c 03 |h 1-3 | ||